Literature DB >> 10855028

Isolation of primary open-angle glaucomatous trabecular meshwork cells from whole eye tissue.

D W Stamer1, B C Roberts, D L Epstein, R R Allingham.   

Abstract

PURPOSE: Isolation and culture of human trabecular meshwork (TM) cells from primary open-angle glaucomatous (POAG) tissue has proven difficult. The objective of this study was to directly compare the utility of two different isolation methods to obtain viable human TM cells from POAG whole eye tissue.
METHODS: Using a blunt dissection technique, human TM tissue was obtained from four pairs of donor eyes (67, 77, 81 and 82 years) with a documented history of POAG. TM tissue from one eye was explanted into tissue culture. TM from the contralateral eye was digested with a collagenase mixture and seeded onto culture plates.
RESULTS: Primary cell isolates were obtained from all donors with both techniques. However, only cells obtained using the digestion method (3 of 4 TMs) could be passaged for expansion and freeze-downs (3 x 107 second passage cells/donor). None of the cells obtained from explanted TMs could be passaged. Cells from successful isolations were of uniform size, possessed typical TM morphology and had doubling times < 48 hours.
CONCLUSION: These results demonstrate a clear advantage to digesting the extracellular matrix of glaucomatous TM tissue to obtain sufficient numbers of healthy cells for use in experiments. In contrast to cells obtained from explants, cells liberated from POAG TM tissue by digestion appear indistinguishable morphologically and behaviorally from "normal" TM cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855028

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  28 in total

1.  Effect of hevin deletion in mice and characterization in trabecular meshwork.

Authors:  Min Hyung Kang; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

2.  Small-molecule inhibition of Wnt signaling abrogates dexamethasone-induced phenotype of primary human trabecular meshwork cells.

Authors:  Sarah D Ahadome; Chi Zhang; Elizabeth Tannous; James Shen; Jie J Zheng
Journal:  Exp Cell Res       Date:  2017-05-17       Impact factor: 3.905

3.  Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.

Authors:  Vibhuti Agrahari; Guorong Li; Vivek Agrahari; Iris Navarro; Kristin Perkumas; Abhirup Mandal; W Daniel Stamer; Ashim K Mitra
Journal:  Nanomedicine (Lond)       Date:  2017-07-31       Impact factor: 5.307

4.  Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.

Authors:  Guorong Li; Gang Cui; W Michael Dismuke; Iris Navarro; Kristin Perkumas; David F Woodward; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2016-12-07       Impact factor: 3.467

5.  Regulation of myocilin-associated exosome release from human trabecular meshwork cells.

Authors:  Emely A Hoffman; Kristin M Perkumas; Lindsey M Highstrom; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

6.  Autophagic dysregulation in glaucomatous trabecular meshwork cells.

Authors:  Kristine Porter; Joshua Hirt; W Daniel Stamer; Paloma B Liton
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 7.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 8.  Biological properties of trabecular meshwork cells.

Authors:  Joshua Z Gasiorowski; Paul Russell
Journal:  Exp Eye Res       Date:  2008-08-26       Impact factor: 3.467

9.  PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells.

Authors:  Nigar Fatma; Eri Kubo; Carol B Toris; W D Stamer; Carl B Camras; Dhirendra P Singh
Journal:  Free Radic Res       Date:  2009-07-01

10.  Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells.

Authors:  Guadalupe Villarreal; Ayan Chatterjee; Sarah S Oh; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.